Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan

World Journal of Gastroenterology

Volumn 11, Issue 23, 2005, Pages 3562-3565

  Yakoob, Javed ^a   Jafri, Wasim ^a   Jafri, Nadim ^a   Islam, Muhammad ^a   Abid, Shahab ^a   Hamid, Saeed ^a   AliShah, Hasnain ^a   Shaikh, Hizbullah ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Acid peptic diseases; H pylori

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; UREASE;

ABDOMINAL PAIN; ADULT; AGED; ANAMNESIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DUODENITIS; DUODENOSCOPY; DUODENUM BLEEDING; DUODENUM ULCER; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELENA; PAKISTAN; PREVALENCE;

EID: 21344466095     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i23.3562     Document Type: Article

References (15)

1. Anon. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 65-69
2. Anon. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997; 41: 8-13
3. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of hemorrhage among older subjects. Gut 2002; 50: 460-464
4. Singh G, Triadafilopoulus G. Epidemiology of NSAID-induced GI complications. J Rheumatol 1999; 26(Suppl 26): 18-24
5. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998; 93: 574-578
6. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. J Clin Gastroenterol 1997; 24: 2-17
7. Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol 1998; 26: 60-63
8. Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States has been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93: 1409-1415
9. Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, Leung WK, Lau JY, Chung SC, Sung JJ. Is non- Helicobacter pylori, non- NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointestinal Endosc 2001; 53: 438-442
10. Nishikawa K, Sugiyama T, Kato M, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagava H, Katagiri M, Nishikawa S, Hokari K, Takeda H, Asaka M. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000; 12: 635-640
11. Qureshi H, Hafiz S, Medhi I. H pylori IgG antibodies in children. J Pak Med Assoc 1999; 49: 143-144
12. Kazi JI, Jafarey NA, Alam SM, Zuberi SJ, Kazi AM, Qureshi H, Ahmed W. Association of Helicobacter pylori with acid peptic disease in Karachi. J Pak Med Assoc 1990; 40: 240-241
13. Ahmed W, Quereshi H, Alam SE, Zuberi SJ. Patterns of duodenal ulcer in Karachi. J Pak Med Assoc 1990; 40: 212-215
14. Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48: 91-132
15. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999; 94: 1834-1840